Cell Signaling and Resistance to Oxidative Stress: Effects of Aging and Exercise
1 other identifier
interventional
46
1 country
1
Brief Summary
Advanced age is the main risk factor for chronic diseases such as cardiovascular disease, type 2 diabetes, Alzheimer's disease and cancer. One reason may be due to decreased resistance to oxidative stress as antioxidant defenses and cell protection is reduced with aging. This has been shown in animal studies and also that the impairment can be somewhat restored with exercise. This will be the first study to test this in humans by comparing young and older inactive adults before and after an exercise intervention, a practical and cost-effective intervention that can have tremendous public health impact by lowering risk for disease and medical-related costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 11, 2018
CompletedFirst Posted
Study publicly available on registry
February 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2020
CompletedAugust 26, 2020
August 1, 2020
3 years
January 11, 2018
August 21, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cell signaling
Nuclear Nrf2 protein content in peripheral mononuclear cells (PBMCs) in response to acute exercise
8 weeks
Resistance to oxidative stress
F2-isoprostane response to forearm ischemia-reperfusion
8 weeks
Secondary Outcomes (1)
Cell signaling
8 weeks
Study Arms (2)
Exercise Intervention
EXPERIMENTAL8-weeks exercise intervention: 3-days per week for 45-55 minutes per session
Control
NO INTERVENTION8-weeks control: asked not to change anything or start exercising.
Interventions
Eligibility Criteria
You may qualify if:
- Men and women, 18-28 years or 60 years and older
- Competent to independently give informed consent
- Successful completion of screening
- No regular exercise for the past 6-months (by self-report)
- A score below 3.0 on the Historical Lifetime Physical Activity Questionnaire
You may not qualify if:
- Estrogen supplementation within the previous 6 months
- Use of anti-oxidant supplements, in excess of standard multi-vitamins (1 tablet/day)
- Current smoker
- Body Mass Index (BMI) ≤33 kg/m2 (Class I Obesity)
- Any chronic illness that could affect outcome measures, including diabetes, liver or renal disease, or cancer (other than skin cancer)
- History of a myocardial infarction within the last 6 months, clinically significant aortic stenosis, use of cardiac defibrillator, or uncontrolled angina
- Clinically significant arrhythmia on a resting EKG or significant EKG changes during the baseline maximal oxygen consumption (VO2 max) test
- Any other condition that would contraindicate maximal exercise testing, including elevated blood pressure at rest (systolic BP \>150 or diastolic BP \>90 mm Hg on at least 2 measurements, at least 10 minutes apart) or musculoskeletal problems
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northern Arizona University
Flagstaff, Arizona, 86011, United States
Related Publications (1)
Ostrom EL, Traustadottir T. Aerobic exercise training partially reverses the impairment of Nrf2 activation in older humans. Free Radic Biol Med. 2020 Nov 20;160:418-432. doi: 10.1016/j.freeradbiomed.2020.08.016. Epub 2020 Aug 28.
PMID: 32866619DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Tinna Traustadóttir, PhD
Northern Arizona University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Biological Sciences
Study Record Dates
First Submitted
January 11, 2018
First Posted
February 5, 2018
Study Start
June 1, 2017
Primary Completion
May 30, 2020
Study Completion
June 30, 2020
Last Updated
August 26, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share